Strategic Investment Advisors’s Definium Therapeutics DFTX Stock Holding History

Strategic Investment Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$110K	Buy	+2,345	New	+$57.9K	0.01%	382

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Strategic Investment Advisors's DFTX Position: Q2 2026 in Review

Strategic Investment Advisors opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 2,345 shares worth $110K. The stake represents 0.01% of the portfolio and ranks #382 among its holdings.

361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Strategic Investment Advisors held 2,345 shares of Definium Therapeutics worth $110K as of Q2 2026.
Definium Therapeutics was a new Strategic Investment Advisors position in Q2 2026.
Definium Therapeutics made up 0.01% of Strategic Investment Advisors's portfolio in Q2 2026, its #382 holding.
361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Strategic Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.